RxDoctor Payments Data

Kathryn Edwards

Family · Greenville, NCNPI 1326554163

Payments from drug & device makers

$568in general payments, 2019–2025

Across 34 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vifor Pharma, Inc.$198
  • Bayer$72
  • AstraZeneca$65
  • Amgen$39
  • Mallinckrodt Hospital Products Inc.$36
  • GSK$36
  • plus $122 from 6 others

What the payments were for

  • Food & beverage$566100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$568 in reported general payments places this provider in the 60th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$41,450
Medicare patients
39
Services billed
1,072

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide19$61,742
Sevelamer Carbonate79$24,482
Lanthanum Carbonate13$7,662
Calcium Acetate14$1,859
Bumetanide18$487
Furosemide37$299
Calcitriol29$272
Amlodipine Besylate50$256
Metoprolol Succinate16$238
Hydralazine Hcl18$137
Losartan Potassium16$112
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$109
Carvedilol28$95
Allopurinol13$46

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$19$61,74219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,522 family providers in North Carolina.

Other family in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →